Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.61 |
| ▸ | LTA4H | P09960 | 4/20 | 0.59 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA7 | P43166 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Methoxy-4-Pentoxybenzene SCHEMBL7778996 | 0.95 | NR5A1 (0.64) | AHRLTA4HNR5A1MAPTL3MBTL1 | |
| SCHEMBL13042288 | 0.93 | NR5A1 (0.68) | AHRLTA4HNR5A1MAPTL3MBTL1 | |
| SCHEMBL13110618 | 0.93 | NR5A1 (0.68) | AHRLTA4HNR5A1MAPTL3MBTL1 | |
| SCHEMBL11983233 | 0.93 | NR5A1 (0.68) | AHRLTA4HNR5A1MAPTL3MBTL1 | |
| SCHEMBL2095782 | 0.93 | NR5A1 (0.68) | AHRLTA4HNR5A1MAPTL3MBTL1 | |
| SCHEMBL23128627 | 0.93 | NR5A1 (0.68) | AHRLTA4HNR5A1MAPTL3MBTL1 | |
| SCHEMBL2951017 | 0.93 | NR5A1 (0.68) | AHRLTA4HNR5A1MAPTL3MBTL1 | |
| 1-Methoxy-4-Propoxybenzene SCHEMBL1324557 | 0.90 | LTA4H (0.57) | AHRLTA4HMAPTL3MBTL1HPGD | |
| SCHEMBL8434882 | 0.90 | CA12 (0.61) | MAPTL3MBTL1HPGDATMCA12 | |
| SCHEMBL9808262 | 0.90 | MAPT (0.62) | MAPTL3MBTL1HPGDATMCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118359513-A | Chain oxamide ligand and application thereof in copper-catalyzed C-O coupling reaction | 广东工业大学 | 2024-07-19 | — | — | CN | disclosed |
| CN-117957123-A | Thermosensitive recording medium | 王子控股株式会社 | 2024-04-30 | — | — | CN | disclosed |
| CN-116490375-A | Thermosensitive recording medium | 王子控股株式会社 | 2023-07-25 | — | — | CN | disclosed |
| US-11000515-B2 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease | SHY Therapeutics LLC (US) | 2021-05-11 | — | — | US | disclosed |
| EP-3394056-B1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC (US) | 2021-04-14 | — | — | EP | disclosed |
| US-20200061037-A1 | COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | SHY THERAPEUTICS, INC. | 2020-02-27 | — | — | US | disclosed |
| WO-2017112777-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC (US) | 2017-06-29 | — | — | WO | disclosed |
| US-20150336925-A1 | SUBSTITUTED BENZOFURAN, BENZOTHIOPHENE AND INDOLE MCL-1 INHIBITORS | VANDERBILT UNIVERSITY (US) | 2015-11-26 | — | — | US | disclosed |
| US-20150224099-A1 | ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 2015-08-13 | — | — | US | disclosed |
| US-8987304-B2 | Antituberculous composition comprising oxazole compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| EP-1223809-A4 | METHODS OF TREATING HAIR LOSS COMPRISING ADMINISTERING INDOLINE COMPOUND | UNIV TEXAS SOUTHWESTERN MED CT (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2003007954-A2 | SULFONYL ARYL HYDROXAMATES AND THEIR USE AS MATRIX METALLOPROTEASE INHIBITORS | PHARMACIA CORPORATION (US) | 2003-01-30 | — | — | WO | disclosed |
| EP-1223809-A1 | METHODS OF TREATING HAIR LOSS COMPRISING ADMINISTERING INDOLINE COMPOUND | UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER (US) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001030151-A1 | METHODS OF TREATING HAIR LOSS COMPRISING ADMINISTERING INDOLINE COMPOUND | THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER (US) | 2001-05-03 | — | — | WO | disclosed |
| EP-0087248-B2 | LIQUID CRYSTAL COMPOSITION CONTAINING AZO DYES | MITSUBISHI KASEI CORPORATION (JP) | 1989-02-08 | — | — | EP | disclosed |
| US-4737310-A | PLEOCHROIC | MITSUBISHI CHEMICAL INDUSTRIES (JP) | 1988-04-12 | — | — | US | disclosed |
| US-4600527-A | AZO DYES, MULT&COLOR, PHOTOCHROMIC | MITSUBISHI CHEMICAL INDUSTRIES (JP) | 1986-07-15 | — | — | US | disclosed |
| EP-0087248-B1 | LIQUID CRYSTAL COMPOSITION CONTAINING AZO DYES | MITSUBISHI KASEI CORPORATION (JP) | 1986-05-28 | — | — | EP | disclosed |
| US-4404354-A | FROM P-DIALKOXYBENZENES, HEAT RESISTANT | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1983-09-13 | — | — | US | disclosed |
| EP-0087248-A1 | Liquid crystal composition containing azo dyes | MITSUBISHI KASEI CORPORATION (JP) | 1983-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150224099-A1 | ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS | OXA1L, ARG1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | AHR 1203/4885LTA4H 813/4885NR5A1 1910/4885 |
| US-11000515-B2 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease | HRAS, KRAS, NRAS | AHR 2195/4885LTA4H 1542/4885NR5A1 2466/4885 |
| US-20150336925-A1 | SUBSTITUTED BENZOFURAN, BENZOTHIOPHENE AND INDOLE MCL-1 INHIBITORS | MCL1, BCL2L1, BCLAF1 | AHR 219/4885LTA4H 3823/4885NR5A1 3973/4885 |
| US-20200061037-A1 | COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | HRAS, KRAS, NRAS | AHR 2195/4885LTA4H 1542/4885NR5A1 2466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.